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Abstract
The effects of 4-hydroxytamoxifen (OHTAM), the major active metabolite of the antiestrogen tamoxifen used in the breast
cancer therapy, were studied on the mitochondrial permeability transition (MPT) and bioenergetic functions of mitochondria to
evaluate the mechanisms underlying the cell death and toxic effects. The MPT was induced in vitro by incubating rat liver
mitochondria with 1 mM inorganic phosphate plus Ca21 and with tert-butyl hydroperoxide. OHTAM provides protection
against the Ca21-induced mitochondrial swelling, depolarization of the mitochondrial membrane potential (DC), loss of
electrophoretic Ca21 uptake capacity and uncoupling of respiration, similarly to cyclosporine A. The concentrations of
OHTAM used do not significantly affect DC , respiratory control and adenosine diphosphate/oxygen ratios and induce repolar-
ization and Ca21 re-uptake, suggesting that such inhibitory effects of OHTAM were due to the prevention of the MPT induction
and not due to the inhibition of the mitochondrial Ca21 uniporter. Since the MPT induction has been linked to an oxidized shift
in the mitochondrial redox state and/or increase in the generation of reactive oxygen species, the MPT prevention by OHTAM
may be related to its high antioxidant capacity. q 2002 Elsevier Science B.V. and Mitochondria Research Society. All rights
reserved.
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1. Introduction
4-Hydroxytamoxifen (OHTAM) is the major active
metabolite of the antiestrogenic drug tamoxifen
(TAM) used in the chemotherapy and prevention of
breast cancer (Jordan, 1990). OHTAM have been
reported to be pharmacologically active, playing an
important role in the therapeutic activity and side
effects of TAM (Kemp et al., 1983). The antiestro-
genic and antiproliferative activities of OHTAM in
vitro are much stronger as compared to TAM (Borgna
and Rochefort, 1981), but the pharmacological rele-
vance of OHTAM has been questioned (McCague et
al., 1990) due to its low serum concentrations (Lien et
al., 1987; MacCallum et al., 1996). However, the
strong affinity of OHTAM for biomembrane proteins
and its higher partitioning in the lipid bilayer as
compared to TAM (Custo´dio et al., 1991), perturbing
the membrane lipid–protein interface (Custo´dio et al.,
1993), suggest that OHTAM may accumulate in
tissues, reaching the required effective concentrations
in the tissues for its cytotoxic effects, as described by
Lien et al. (1991). Moreover, it has been established
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that OHTAM does not induce proliferative or neoplas-
tic lesions, genotoxicity (Sauvez et al., 1999), erythro-
cyte hemolysis (Cruz Silva et al., 2001) and it is
pharmacologically well tolerated as compared to
TAM (Sauvez et al., 1999) whose therapeutical use
is now questionable. In fact TAM may increase the
incidence of liver (Williams et al., 1993) and endo-
metrial (Fisher et al., 1994) cancers, induction of
genotoxicity (Davies et al., 1995), hemolytic anemia
(Ching et al., 1992; Suwalsky et al., 1998; Cruz Silva
et al., 2000), hepatic and cardiac lesions (Kargacin et
al., 2000), suggesting OHTAM as a more advanta-
geous drug in the breast cancer therapy. The use of
OHTAM in malignant and non-malignant breast
cancer diseases by topical application is undergoing
clinical evaluation as an alternative route to TAM
treatment (Mauvais-Jarvis et al., 1986) and pharma-
cological studies to evaluate differences between the
percutaneous and the oral routes have been performed
(Pujol et al., 1995; Sauvez et al., 1999). Therefore,
studies of cytotoxic effects of OHTAM and the under-
lying molecular mechanisms are required to assure a
safe and appropriate therapeutical administration of
the drug.
Mitochondria have been implicated as an important
subcellular site of damage induced by several xeno-
biotics and interference on mitochondrial bioener-
getics is known to be involved in the process of
lethal cell injury induced by xenobiotics, leading to
cellular ATP depletion and cell death (Wallace et al.,
1997; Wallace and Starkov, 2000). Additionally, the
mitochondrial permeability transition (MPT) has been
implicated in the mitochondrial and cellular Ca21
homeostasis, in cell defense (Bernardi, 1996) and in
the mechanisms of toxic tissue injury caused by differ-
ent compounds, the majority of which are oxidants
(Zoratti and Szabo, 1995; Wallace et al., 1997).
Besides the proposed role of the MPT in the cell
life, different studies have provided further support
for the central role of the MPT in various intracellular
signalling pathways including apoptotic program
(Bernardi, 1996; Ichas and Mazat, 1998). Since
prooxidants, that oxidize mitochondrial membrane
protein sulfhydryl groups, mitochondrial matrix
GSH and nucleotides [NAD(P)H], are known to
induce the MPT (Petronilli et al., 1994; Constantini
et al., 1996), OHTAM, owing to its antioxidant prop-
erties (Custo´dio et al., 1994), may inhibit MPT.
Therefore, the aim of this work was to study the
effects of OHTAM on both mitochondrial bioener-
getics and MPT to contribute to the understanding
of the molecular mechanisms underlying the action
and cytotoxicity of OHTAM. Some of these data
have been presented elsewhere in preliminary form
(Cardoso et al., 2000).
2. Materials and methods
2.1. Chemicals
4-Hydroxytamoxifen (OHTAM), 4-(2-hydroxy-
methyl)-1-piperazineethanesulfonic acid (HEPES),
bovine serum albumin (BSA), cyclosporine A (CyA),
oligomycin and tert-butyl hydroperoxide 70% aqueous
solution (t-BuOOH) were purchased from Sigma
Chemical Co. (St. Louis, MO). Ethylene glycol-
bis(b-aminoethyl ether)NNN 0N 0-tetraacetic acid
(EGTA), tetraphenylphosphonium (TPP1) and
sucrose were from MercK (Darmstadt, Germany).
All the chemicals were commercial products of the
highest purity grade available.
2.2. Rat liver mitochondria
Mitochondria were isolated from the liver of rats
(Wistar) of either sex, fasted overnight, by differential
centrifugation as described elsewhere (Custo´dio et al.,
1998). Animals were killed by decapitation and the
liver was quickly homogenized. The homogenate was
prepared at 48C in 250 mM sucrose, 10 mM HEPES
(pH 7.4), 1 mM EGTA and 0.1% BSA free fatty acid,
which was added just prior to use, and centrifuged for
10 min at 1200 £ g. The mitochondrial pellet was
resuspended in the washing medium, adjusted to pH
7.2 in the absence of EGTA and BSA, and mitochon-
dria washed twice were recovered from the superna-
tant at 10,000 £ g for 10 min. Mitochondrial protein
was measured by the method of Biuret (Gornall et al.,
1949) with BSA as protein standard.
2.3. Standard incubation procedure
The experiments were carried out at 258C in a stan-
dard reaction medium containing 200 mM sucrose,
10 mM Tris–Mops (pH 7.4), 1 mM KH2PO4, and
10 mM EGTA, supplemented with 2 mM rotenone
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and 0.5 mg oligomycin/ml. OHTAM was added in
aliquots of a stock ethanolic solution to the reaction
medium after protein addition and incubated for 3 min
before starting the reactions. Other additions were as
indicated in the figure legends. The results shown
represent typical recordings from experiments of at
least three different mitochondrial preparations.
2.4. Mitochondrial swelling
Changes in mitochondrial osmotic volume were
monitored by the decrease in apparent absorbance
(light-scattering) at 540 nm, with a Perkin–Elmer
Lambda 6 UV/VIS spectrophotometer computer
controlled (Norwalk, USA). Mitochondria were
suspended at 0.5 mg protein/ml in 2 ml of standard
reaction medium and the reaction was started with
5 mM succinate. CaCl2 (140 nmol/mg protein) was
added 2 min after energization of mitochondria with
succinate. In some of the experiments, the standard
reaction medium was supplemented with 100 mM t-
BuOOH before energization of mitochondria at 258C
and Ca21 addition (100 nmol/mg protein). Where
indicated, OHTAM or CyA in ethanolic solutions
was added before or after starting the reactions.
2.5. Mitochondrial membrane potential (DC )
The mitochondrial membrane potential (DC ) was
monitored by evaluating transmembrane distribution
of tetraphenylphosphonium (TPP1) with an ion-selec-
tive electrode prepared according to Kamo et al.
(1979) using a Ag/AgCl2 electrode as reference
(model MI 402; Microelectrodes, Inc., Bedford,
NH). Reactions were carried out in an open vessel
with magnetic stirring in 2 ml of standard reaction
medium supplemented with 4 mM TPP1. The experi-
ments were started by adding 5 mM succinate to mito-
chondria in suspension at 0.5 mg protein/ml and
CaCl2 (140 nmol/mg protein) was added after
steady-state distribution of TPP1. Membrane poten-
tial was estimated from the decrease of TPP1 concen-
tration in the medium as described elsewhere (Kamo
et al., 1979; Moreno and Madeira, 1991). OHTAM
and CyA were incubated 2 min before succinate or
after mitochondrial loading with Ca21 as indicated
in the figure legends.
2.6. Mitochondrial oxygen consumption and
membrane potential measurements
Mitochondria (1 mg/ml) were suspended in respira-
tory medium containing 130 mM sucrose, 50 mM
KCl, 2.5 mM MgCl2, 2.5 mM KH2PO4, 5 mM
HEPES and 0.1 mM EGTA supplemented with
2 mM rotenone and 4 mM TPP1. The incubations
were conducted at 258C in a closed reaction chamber
with constant stirring. Oxygen tension was monitored
polarographically with a Clark-type electrode (Estrab-
rook, 1967) and DC was measured with a TPP1 elec-
trode, as described before, inserted through an air-
tight port into the oxygen vessel to monitor oxygen
consumption and DC simultaneously. The reactions
were initiated by adding succinate to a final concen-
tration of 5 mM. After reaching the maximum DC ,
ADP (150 nmol) was added to initiate state 3 respira-
tion and oxygen tension was monitored continuously
until state 4 respiration was resumed.
2.7. Mitochondrial Ca21 fluxes
Mitochondrial Ca21 fluxes were measured by moni-
toring the changes in Ca21 concentration in the reac-
tion medium using a Ca21-selective electrode
(Madeira, 1975; Moreno and Madeira, 1991). The
reactions were conducted in an open vessel with
magnetic stirring in 2 ml of the reaction medium
containing 200 mM sucrose, 10 mM Tris–Mops (pH
7.4), 1 mM KH2PO4, and 10 mM EGTA, supplemen-
ted with 2 mM rotenone and 1 mg oligomycin. Mito-
chondria (0.5 mg protein/ml) were energized with
5 mM succinate after 2 min of Ca21 addition in the
absence (control) and presence of OHTAM and CyA.
In other experiments, OHTAM and CyA were added
at different times after adding Ca21 to the succinate-
energized mitochondria.
3. Results
Mitochondria energized with succinate in the
presence of Ca21 (140 nmol/mg protein) and 1 mM
inorganic phosphate (Pi) undergo a rapid and large
decrease in the absorbance at 540 nm which suggests
complete swelling of mitochondria (Fig. 1A, Control).
This extensive effect is completely prevented by pre-
incubating mitochondria with 10 and 20 nmol
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OHTAM/mg protein, similarly to what happens with
CyA (1.7 nmol/mg protein), a specific and potent inhi-
bitor of the MPT (Broekemeier et al., 1989), suggest-
ing that OHTAM completely protects against the
Ca21-dependent MPT.
The protection of mitochondrial swelling afforded
by OHTAM is observed either when the drug
(20 nmol OHTAM/mg protein) is added before (Fig.
1A) or after (Fig. 1B) energization of mitochondria
with succinate and loading with Ca21, providing
evidence that OHTAM neither causes membrane
depolarization nor interferes with the Ca21 uniporter.
The inhibition of the Ca21 plus Pi-induced mito-
chondrial swelling by OHTAM is a function of
elapsed time, so that the longer the delay in adding
OHTAM, the less pronounced is the inhibition of
swelling (Fig. 2, traces 1–5), demonstrating that
OHTAM is very efficient as inhibitor of the progres-
sive swelling of isolated mitochondria in suspension,
induced by the combination of Ca21 plus Pi.
The inhibitory effect of OHTAM on induction of
the MPT by Ca21 plus Pi is also demonstrated by the
fact that OHTAM prevents the Ca21-induced depolar-
ization of mitochondrial membrane potential (DC )
associated with MPT induction (Fig. 3). The addition
of Ca21 (180 nmol/mg protein) causes a transient
depolarization with DC returning to near 205 mV
within 1.5 min. The repolarization of DC after Ca21
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Fig. 2. Time-dependent inhibition of mitochondrial swelling by
OHTAM. Experimental conditions were identical to those described
in the legend to Fig. 1, except that OHTAM (20 nmol/mg protein)
was added at different times after adding Ca21 (140 nmol/mg
protein) to the succinate-energized mitochondria. The control
trace refers to the experiment with Ca21 1 Pi alone.
Fig. 1. Inhibition of mitochondrial swelling by OHTAM. Rat liver
mitochondria incubated at 0.5 mg protein/ml in 200 mM sucrose–
10 mM Tris-Mops (pH 7.4),1 mM KH2PO4, 10 mM EGTA, supple-
mented with 2 mM rotenone and 0.5 mg/ml oligomycin were ener-
gized with 5 mM succinate at 258C. Light scattering was monitored
continuously at 540 nm for assessing changes in mitochondrial
volume. Where indicated, OHTAM (10 and 20 nmol/mg protein)
or CyA (1.7 nmol/mg protein) was included in the reaction medium
just prior to adding Ca21 (140 nmol/mg protein) (A) and after succi-
nate and Ca21 addition (B). Control refers to the experiment in the
absence of either OHTAM or CyA.
accumulation is followed by a dramatic and irrever-
sible depolarization of mitochondria over the course
of the next 10 min (Fig. 3, control). Pre-incubating
with antiestrogen OHTAM prior to adding succinate
and Ca21 affords complete protection against the
Ca21-induced irreversible depolarization of DC
(Fig. 3) similarly to CyA. Under these conditions,
the Ca21 uptake still causes a transient depolarization
of DC and mitochondria have capacity to sustain this
membrane potential. Moreover and similarly to what
is observed for mitochondrial swelling (Fig. 2), the
effect of OHTAM in preventing the Ca21-induced
depolarization of DC is dependent on the time
elapsed after the addition of Ca21 (Fig. 4). In fact,
OHTAM reverses the Ca21-induced membrane depo-
larization if added before the complete depolarization
of mitochondria (Fig. 4, traces 1–4).
Further evidence that OHTAM inhibits the Ca21-
induced MPT is provided by the fact that it also
prevents the release of mitochondrial loaded Ca21
(Fig. 5). Mitochondria energized with succinate
release the accumulated Ca21 within about 15 min
(Fig. 5, control) but co-incubation with OHTAM
prevents this effect similarly to what is observed
with CyA, enabling mitochondria with the capacity
to accumulate and sustain the added Ca21. Moreover,
adding OHTAM during the time course of the MPT
reverses the Ca21 release (Fig. 6, traces 1–3) in agree-
ment with the repolarization effect (Fig. 4). The effect
of OHTAM in inducing the Ca21 re-uptake is depen-
dent on the time elapsed after the addition of Ca21
(Fig. 6), as observed for mitochondrial swelling
(Fig. 2). OHTAM induces Ca21 re-uptake if added
before the complete release of the cation from mito-
chondria (Fig. 6, traces 1–3). CyA, even when added
late in the reaction, causes total re-uptake of the
released Ca21 (Fig. 6, CyA trace). However, unlike
to what was observed in the DC repolarization (Fig.
4) and for Ca21 re-uptake (Fig. 6), OHTAM does not
reverse the changes occurred on the mitochondrial
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Fig. 4. OHTAM induces repolarization after MPT induced by Ca21
(140 nmol/mg protein) plus 1 mM Pi. The reactions were carried out
as described for Fig. 3 except that OHTAM (20 nmol/mg protein)
was added at different times after mitochondria Ca21 accumulation
(traces 1–4). The control trace corresponds to Ca21 1 Pi alone and
the trace labeled CyA (6) represents the effect of 1.7 nmol/mg
protein CyA added late during the pore transition, as indicated by
the corresponding labeled arrow. Mitochondrial depolarization and
repolarization were monitored by following DC with a TPP1-selec-
tive electrode. All the traces are representative of several separate
experiments.
Fig. 3. Effects of OHTAM on mitochondrial depolarization asso-
ciated with MPT induction. Mitochondria (1 mg) suspended in stan-
dard reaction medium supplemented with 4 mM TPP1 were pre-
incubated for 3 min at 258C in the absence (Control) and in the
presence of either 20 nmol OHTAM/mg protein or 1.7 nmol/mg
protein CyA. The reactions were started with 5 mM succinate and
Ca21 (140 nmol/mg protein) was added after steady state distribu-
tion of TPP1. Mitochondrial membrane potential (DC) was moni-
tored with a TPP1-sensitive electrode. The traces are typical of
several experiments with different mitochondrial preparations.
volume (Fig. 2), similarly to CyA. In fact, swelling
itself is thought to occur because matrix proteins are
slow to equilibrate through the permeability defect as
compared to smaller solutes. This creates a colloid
osmotic pressure imbalance which drives the entrance
of water, resulting in dilution of the matrix with
consequent decrease in absorbance. The population
of mitochondria that have already undergone this
process have been equilibrated with water and solutes
and this is not reversed.
To clarify the mechanisms by which OHTAM inhi-
bits the MPT, its effects on MPT induced by t-BuOOH
and Ca21 were studied. Incubation of succinate-ener-
gized mitochondria with Ca21 (100 nmol) in the
presence of 100 mM t-BuOOH causes a large-ampli-
tude decrease in light scattering (Fig. 7, Control) indi-
cating the occurrence of mitochondrial swelling due to
MPT induction since this effect is prevented by CyA
(Fig. 7A). Pre-incubation with OHTAM (20 nmol/mg
protein) protects mitochondria against mitochondrial
swelling induced by the combination of Ca21 plus t-
BuOOH (Fig. 7A, OHTAM trace) similarly to what
happens with the swelling induced by Ca21 plus Pi
(Fig. 1A). Therefore, t-BuOOH increases the sensitiv-
ity of mitochondria to Ca21-induced swelling (Fig. 7A,
control), since Ca21 alone (Fig. 7A, Ca21 trace) or t-
BuOOH alone (Fig. 7A, t-BuOOH trace) in mitochon-
drial suspensions does not cause any decrease in the
absorbance. The inhibitory effect of OHTAM on MPT
induced by t-BuOOH plus Ca21 is also a function of
elapsed time, the longer OHTAM is added to the mito-
chondrial suspension, the less pronounced is the inhi-
bition of swelling (Fig. 7B). OHTAM inhibits the
continuance of swelling induced by Ca21 plus t-
BuOOH, similarly to what happens with the swelling
induced by the combination of Ca21 plus Pi in mito-
chondrial suspensions. CyA added during the progres-
sion of the swelling arrests the continuance of this
phenomenon, as in the case of Ca21 plus Pi induced
swelling (data not shown).
In order to verify whether the OHTAM concentra-
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Fig. 6. OHTAM induces Ca21 re-uptake by mitochondria after MPT
induction by Ca21 (180 nmol) plus Pi. The reactions were carried
out as described for Fig. 5 except that OHTAM (20 nmol/mg
protein) was added at different times during the course of MPT
(traces 1–3). The control trace corresponds to Ca21 1 Pi alone
and the trace labeled CyA represents the effect of 1.7 nmol/mg
protein CyA added late during MPT. All the traces are representa-
tive of several separate experiments.
Fig. 5. Inhibitory effect of OHTAM on mitochondrial Ca21 release
related to MPT induction. Mitochondria (1 mg) suspended in 2 ml
of standard reaction medium containing 200 mM sucrose–10 mM
Tris–Mops (pH 7.4)–1 mM KH2PO4–10 mM EGTA, supplemented
with 2 mM rotenone and 0.5 mg/ml oligomycin at 258C, were ener-
gized with 5 mM succinate in the absence (control) and presence of
20 nmol OHTAM/mg protein or 1.7 nmol/mg protein CyA prior to
adding 180 nmol Ca21/mg protein. The uptake of Ca21 and release
of sequestered Ca21 by mitochondria were monitored using a Ca21-
selective electrode. The traces are representative of several separate
experiments.
tions used to inhibit the MPT affect mitochondrial
bioenergetics, the effects of OHTAM on DC and
oxygen consumption were evaluated. The concentra-
tions of OHTAM used to inhibit MPT do not affect
significantly both DC and the respiratory chain (Fig.
8), as evaluated simultaneously with a TPP1 or an
oxygen-sensitive electrode, respectively, placed in
the same closed reaction chamber. Pre-incubation of
mitochondria with OHTAM only slightly depresses
the total DC developed (210 mV) (Figs. 8 and 9).
Moreover, OHTAM, up to a concentration of either
10 nmol/mg protein (Fig. 9A) or 20 nmol/mg protein
(Fig. 9B) does not alter significantly state 3 and state 4
respiration, indicating that the respiratory control ratio
is not affected by this drug at these concentrations.
The phosphorylation efficiency of mitochondria is
not also changed since OHTAM does not affect DC
fluctuations associated with mitochondrial energiza-
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Fig. 8. Effects of OHTAM on DC and state 4 respiration. Mitochon-
dria (1 mg/ml) were suspended in 130 mM sucrose, 50 mM KCl,
2.5 mM MgCl2, 2.5 mM KH2PO4, 5 mM HEPES and 0.1 mM
EGTA supplemented with 2 mM rotenone and 4 mM TPP1. Reac-
tions were conducted at 258C in a closed reaction chamber with
constant stirring and experiments were started by adding 5 mM
succinate to the mitochondrial suspension. Where indicated 5, 10
or 20 nmol OHTAM/mg protein were added after steady-state
distribution of TPP1. Mitochondrial respiration rates and DC
were evaluated simultaneously using a Clark-type oxygen electrode
and a TPP1-selective electrode, respectively, inserted in the same
closed reaction chamber. The numbers under or above the traces
indicate the rates of O2 consumption. The traces are typical of
several independent experiments.
Fig. 7. Inhibitory effect of OHTAM on the MPT induced by Ca21
plus tert-butylhydroperoxide (t-BuOOH). Succinate-energized
mitochondria (0.5 mg protein/ml) in 200 mM sucrose, 10 mM
Tris–Mops (pH 7.4), 1 mM KH2PO4, 10 mM EGTA supplemented
with 2 mM rotenone, 0.5 mg/ml oligomycin, at 258C, were incu-
bated with t-BuOOH (100 mM) plus Ca21(100 nmol/mg protein)
in the absence (control) and presence of either OHTAM (20 nmol/
mg protein) (OHTAM) or 1.7 nmol/mg protein CyA (CyA). Traces
of (Ca21) and (t-BuOOH) refer to experiments with Ca21 or t-
BuOOH alone, respectively (A). OHTAM (20 nmol/mg protein)
was also added at different times after Ca21 addition to t-BuOOH
supplemented mitochondria, as indicated by the arrows (B). Light
scattering was monitored continuously at 540 nm for assessing
changes in mitochondrial volume. The traces are typical of several
independent experiments.
tion, phosphorylative cycle induced by ADP or ADP/
O ratio (Fig. 9A,B).
4. Discussion
Induction of the Ca21-dependent MPT has been
implicated in several cellular events, namely, in the
mitochondrial and cellular Ca21 homeostasis, in cell
defense, apoptotic cell death (Bernardi, 1996) and in
the mechanisms of toxic tissue injury (Wallace et al.,
1997). It results in a rapid dissipation of electroche-
mical gradients leading to depolarization of DC ,
mitochondrial swelling, release of low-molecular-
weight solutes, including Ca21 and GSH, uncoupling
of respiration and inhibition of ATP synthesis (Ichas
and Mazat, 1998; Bernardi et al., 1999).
This work demonstrates that OHTAM prevents the
Ca21-dependent swelling (Figs. 1, 2 and 7),
membrane depolarization (Fig. 3) and the release of
the accumulated Ca21 (Fig. 5). Also, it affords to
mitochondria capacity to recover the DC (Fig. 4)
and to sequester some Ca21 released (Fig. 6), when
added during the time course of the reactions. Accord-
ingly, OHTAM also prevents mitochondrial swelling
when added after energization of mitochondria with
succinate and loading with Ca21 (Figs. 1B and 2),
providing evidence that OHTAM neither causes
membrane depolarization nor interferes with the
Ca21 uniporter. Moreover, OHTAM does not alter
significantly either the DC and state 4 respiration
(Fig. 8) or the phosphorylation efficiency of mito-
chondria (Fig. 9), suggesting that the preventive
effects of OHTAM against induction of the MPT are
not likely to have a direct effect on the electron trans-
port chain.
Reversible permeabilization of the inner mitochon-
drial membrane induced by Ca21 ions plus prooxi-
dants is under the regulatory influence of the redox
status of both mitochondrial nucleotides, matrix sulf-
hydryl groups and membrane protein thiols forming
cross-linked protein aggregates (Fagian et al., 1990;
Petronilli et al., 1994; Bernardi, 1996; Halestrap et al.,
1997). In addition to the oxidation of sulfhydryl
groups and nucleotides [NAD(P)H], the generation
of reactive oxygen species (ROS) within mitochon-
dria (or a decreasing in their detoxification) contri-
butes to the induction of the MPT, as shown by
studies with several MPT inducers, including t-
BuOOH (Castilho et al., 1996; Nieminen et al.,
1995; 1997; Kowaltowski et al., 2000) and Pi (Kowal-
towski et al., 1996, 1998). Moreover, the prooxidants
mediated exhaustion of mitochondrial GSH and
NAD(P)H, lead to the depletion of substrates of the
antioxidant enzymes glutathione peroxidases and
glutathione reductase, respectively (Valle et al.,
1993; Castilho et al., 1996), important components
of the mitochondrial antioxidant defense system.
Ca21 and prooxidants seem to play a concerted role
in ROS accumulation within mitochondria (Castilho
et al., 1996; Byrne et al., 1999). In fact t-BuOOH was
unable to cause mitochondrial swelling in the absence
of Ca21 (Fig. 7A, t-BuOOH), according to what has
also been observed by Kushnareva and Sokolove
(2000), suggesting that this cation is essential and
must act in additional steps in the sequence of events
that lead to mitochondrial permeabilization. The bind-
ing of Ca21 to the inner membrane may cause confor-
mational changes to critical proteins that expose thiol
groups to the action of oxidants (Fagian et al., 1990;
Valle et al., 1993).
Since both Ca21 plus Pi and Ca
21 plus t-BuOOH-
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Fig. 9. Effect of OHTAM on mitochondrial respiratory chain
(dashed line) and DC (solid line). The reaction was carried out
under the similar conditions referred to Fig. 8. Where indicated
10 (A) or 20 nmol OHTAM/mg protein (B), ADP (150 nmol) and
FCCP (1 nmol/mg protein) were added. Respiration rates and DC
were evaluated simultaneously using a Clark-type electrode and a
TPP1-selective electrode, respectively, placed in the same closed
reaction chamber. The traces represent typical direct recordings
from several independent experiments with different mitochondrial
preparations.
induced swelling are dependent on the oxidative stress
generated within the mitochondria (Kowaltowski et
al., 1996, 2000) and considering that OHTAM is an
efficient intramembraneous inhibitor of lipid peroxi-
dation (Custo´dio et al., 1994), it is reasonable to
suggest that OHTAM influences the regulation of
the permeability transition by a mechanism related
to its incorporation in the membrane and dependent
on its antioxidant/scavenging activities (Custo´dio et
al., 1994). In fact, the stronger OHTAM intramembra-
neous scavenger capacity (Custo´dio et al., 1994) and
partition in biomembranes (Custo´dio et al., 1991) over
TAM parallels its potency against MPT induction
[20 nmol OHTAM/mg protein inhibit the MPT
whereas the same effect is only observed with
40 nmol TAM/mg protein (Custo´dio et al., 1998)].
Further studies on thiol groups, NAD(P)H and GSH
oxidation, already in progress in our laboratory, would
help in better elucidating this mechanism of action of
OHTAM.
Owing to its antioxidant effects, OHTAM could
protect mitochondria from undergoing irreversible
permeabilization, a process that leads to the mito-
chondrial large amplitude swelling and causes the
release of factors that activate the apoptogenic cata-
bolic enzymes, due to mechanical disruption of the
outer mitochondrial membrane (Skulachev, 1996;
Petit et al., 1998). Considering that MPT triggering
may cause apoptosis and its inhibition can prevent this
process of cell death (Petit et al., 1998), the relevance
of MPT inhibition to the OHTAM efficacy as an anti-
cancer drug may be questionable. However, similar to
what has been postulated for CyA in induction of
lymphoma P388 cell death (Teplova et al., 2000), it
is possible that OHTAM might induce tumor cell
death as a result of MPT closing, protecting mitochon-
dria from an osmotic shock as a result of periodic
decrease in DC and efflux of cations from mitochon-
dria, periodically releasing Ca21, thus aiding the func-
tioning of mitochondria in the system of spatial
transduction of Ca21 signal in cells.
In conclusion, our data indicate that the MPT inhi-
bition by OHTAM relies on its antioxidant activities
since in these concentrations the drug neither affects
mitochondrial bioenergetic parameters nor the func-
tions of the mitochondrial Ca21 uniporter. Moreover,
considering that reversible partial openings of MPT in
tumor cells can play an essential role in their vital
activity in several ways, MPT closing by OHTAM
may be implicated in its mechanisms of anticancer
action.
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